Pfizer Report 2011
Contents
Notice Directors’ Report including Management Discussion and Analysis Report Report on Corporate Governance Auditors’ Report Balance Sheet Profit and Loss Account Cash Flow Statement Notes
4
14 24 38 44 45 46 48
1
Year Summary Ten Year Financial Summary
` in Lakhs Nov 2002± Sources Sources of Funds Shareholders’Fund Share Capital Share Capital Suspense A/c Reserves and Surplus Total Shareholders’ Funds Borrowed Funds Secured Loans Unsecured Loans Total Application of Funds Net Fixed Assets Investments Deferred Tax Asset (Net) Current Assets, Loans and Advances; Inventories Sundry Debtors Cash and Bank Balances Other Current Assets Loans & Advances Total Currents Assets, Loans and Advances Less: Current Liabilites and Provisions Current Liabilities Provisions Net Current Assets Misc Expenditure (Deferred Revenue Expenditure) Voluntary Retirement Schemes Total Income Gross Sales Less : Excise Duty Less : Sales Tax Net Sales Operating and Other Income Total Expenditure Expenditure Material Cost Personnel Cost Manufacturing and Other Expenses Interest Expense / Finance Cost Depreciation and amortization Total rofit Before Taxation P rofit Before Taxation and Exceptional Items Exceptional Items -Net rofit Before Taxation P rofit Before Taxation Taxation rofit Taxation P rofit After Taxation Tax Provision as a % of PBT Net Profit as a % of Sales Earnings Per Share (`) Equity Dividend Per Share (`) Total Dividend Amount (` in Lakhs) Book Value per share (`) ± § # ** ^ Includes Includes Includes Includes Includes Nov 2003 Nov 2004§ Nov 2005 Nov 2006 Nov 2007 Nov 2008 Nov 2009^ Mar 2011 16 months Mar 2012
2344 536 27923 30803 30803 5696 529 790 8484 12341 6840 7260 34925 11112 5244 18569 5219 30803 65127 5719 5165 54243 6007 60250 21978 8784 17183 76 1064 49085 11165 1518 12683 5089 7594 40.1 11.7 26.37 7.50 2160 106.95
2880 27960 30840 30840 6110 324 989 8658 5883 8908 45 8330 31824 9619 4192 18013 5404 30840 55896 3954 4478 47464 4051
Notice Directors’ Report including Management Discussion and Analysis Report Report on Corporate Governance Auditors’ Report Balance Sheet Profit and Loss Account Cash Flow Statement Notes
4
14 24 38 44 45 46 48
1
Year Summary Ten Year Financial Summary
` in Lakhs Nov 2002± Sources Sources of Funds Shareholders’Fund Share Capital Share Capital Suspense A/c Reserves and Surplus Total Shareholders’ Funds Borrowed Funds Secured Loans Unsecured Loans Total Application of Funds Net Fixed Assets Investments Deferred Tax Asset (Net) Current Assets, Loans and Advances; Inventories Sundry Debtors Cash and Bank Balances Other Current Assets Loans & Advances Total Currents Assets, Loans and Advances Less: Current Liabilites and Provisions Current Liabilities Provisions Net Current Assets Misc Expenditure (Deferred Revenue Expenditure) Voluntary Retirement Schemes Total Income Gross Sales Less : Excise Duty Less : Sales Tax Net Sales Operating and Other Income Total Expenditure Expenditure Material Cost Personnel Cost Manufacturing and Other Expenses Interest Expense / Finance Cost Depreciation and amortization Total rofit Before Taxation P rofit Before Taxation and Exceptional Items Exceptional Items -Net rofit Before Taxation P rofit Before Taxation Taxation rofit Taxation P rofit After Taxation Tax Provision as a % of PBT Net Profit as a % of Sales Earnings Per Share (`) Equity Dividend Per Share (`) Total Dividend Amount (` in Lakhs) Book Value per share (`) ± § # ** ^ Includes Includes Includes Includes Includes Nov 2003 Nov 2004§ Nov 2005 Nov 2006 Nov 2007 Nov 2008 Nov 2009^ Mar 2011 16 months Mar 2012
2344 536 27923 30803 30803 5696 529 790 8484 12341 6840 7260 34925 11112 5244 18569 5219 30803 65127 5719 5165 54243 6007 60250 21978 8784 17183 76 1064 49085 11165 1518 12683 5089 7594 40.1 11.7 26.37 7.50 2160 106.95
2880 27960 30840 30840 6110 324 989 8658 5883 8908 45 8330 31824 9619 4192 18013 5404 30840 55896 3954 4478 47464 4051